Skip to main content

The EURESI project


The situation of clinical research in Europe must be improved substantially according to statements of scientists, managers and politicians. The analysis of requirements is available; however, there are no indications that the conclusion of the analysis is being converted into actual facts. Government programs, although originally conceived to improve the situation of clinical research, are used to maintain the status quo. The European Research Network on Surgical Infections (EURESI) concept has been developed by scientists and clinicians from European institutions and university hospitals to make the first steps possible in a new cooperation in European research. With regard to the essentials for clinical research, formulated according to a survey among research-oriented pharmaceutical companies, EURESI was successful in the following objectives: 1) competence in clinical research, 2) capacity for clinical studies, 3) internal quality control, 4) special know-how relevant to clinical studies, 5) performance according to a time plan, 6) interdisciplinianism, 7) contract partnership, 8) organization of research meetings. This special addendum includes presentations at the EURESI meeting in Heidelberg/Weinheim with special reference to the requirements for clinical studies in intraabdominal infections to further stimulate contact with the network.

This is a preview of subscription content, access via your institution.


  1. 1.

    Gallin, J. I., Smits, H. L.: Managing the interface between medical schools, hospitals, and clinical research. JAMA 277 (1997) 651–654.

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Baumbauer, E.: Klinische Arzneimittelforschung in Deutschland—Eine Standortbestimmung aus Sicht der Industrie. Langenbecks. Arch. Chir. Suppl. II (1996) 646–650.

    Google Scholar 

  3. 3.

    Ramsch, K. D.: Experiences with GCP in the pharmaceutical industry. Methods Find. Exp. Clin. Pharmacol. 15 (1993) 237–240.

    PubMed  CAS  Google Scholar 

  4. 4.

    Hannisdal, E.: Clinical research in a hospital—from the lone rider to teamwork. Acta Oncol. 35 (1996) (Suppl. 8) 35–39.

    PubMed  Article  Google Scholar 

  5. 5.

    Holzheimer, R. G.: Klinische Forschung in Deutschland— Universität und Industrie als gleichwertige Partner? In:Hollerith, J. (ed.): Leistungsfähige Hochschulen—aber wie? Luchterhand. Neuwied 1997, pp. 111–119.

    Google Scholar 

  6. 6.

    Ebert, K., Krebs, R.: Interaktion der industriellen und akademischen Forschung in der Bundesrepublik am Beispiel der Pharmaindustrie. In:Hollerith, J. (ed.): Leistungsfähige Hochschulen—aber wie? Luchterhand, Neuwied 1997, pp. 157–174.

    Google Scholar 

  7. 7.

    Schwarz, R. P.: Maintaining integrity and credibility in industry-sponsored clinical research. Controled Clin. Trials 12 (1991) 753–760.

    Article  Google Scholar 

  8. 8.

    Blumenstein, B. A., James, K. E., Lind, B. K., Mitchell, H. E.: Functions and organization of coordinating centers for multicenter studies. Controlled clinical trials. Design, methods, and analysis. Abstr. 16 (1995) 4S-29S.

    CAS  Google Scholar 

  9. 9.

    Holzheimer, R. G.: Fast cytokine analysis as part of a European research network. Shock 8 (Suppl.) (1997) 37.

    Google Scholar 

  10. 10.

    Holzheimer, R. G., Cavaillon, J. M., Aasen, A. O., Cainzos, M., Schöffel, U.: Clinical routine cytokine determination as part of a European research network. Shock 7 (Suppl.) (1997) 121.

    Google Scholar 

  11. 11.

    Poy, E.: Objectives of QC systems and QA function in clinical research. Qual. Assur. 2 (1993) 326–331.

    PubMed  CAS  Google Scholar 

  12. 12.

    Goodson, R. L.: Good clinical practice: past, present, and future. Qual. Assur. 4 (1995) 60–67.

    PubMed  CAS  Google Scholar 

  13. 13.

    Holzheimer, R. G., Hirte, J. F., Reith, B., Engelhardt, W., Horak, K. H., Leppert, R., Aasen, A., Capel, P., Urbaschek, R., Karch, H., Thiede, A.: Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients. J. Endotoxin Res. 3 (1996) 261–267.

    CAS  Google Scholar 

  14. 14.

    Holzheimer, R. G., Cavaillon, J. M., Mosca, F., Haupt, W., Stefani, A., DiStefano, R., Torres, A., Capel, P., Aasen, A., Anderson, I., Schoeffel, U.: Clinical and basic science aspects of immune pathogenesis of sepsis and peritonitis. Med. Microbiol. Letters 5 (1996) 386–393.

    Google Scholar 

Download references

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

Holzheimer, R.G. The EURESI project. Infection 26, 323–328 (1998).

Download citation


  • Clinical Research
  • Time Plan
  • Internal Quality Control
  • Intraabdominal Infection
  • Research Meeting